TransSafeTM Mycoplasma Prevention Reagent
支原体预防试剂
| 目录号 | 规格 | 单价 |
|---|---|---|
| FM501-01 | 1 ml | 290 |
| FM501-02 | 5×1 ml | 1100 |
产品详情介绍
本产品是对支原体具有抑制作用的三种抗生素的混合物，分别为大环内酯类、氟喹诺酮类和四环素类衍生物抗生素，可以有效干扰支原体的蛋白表达和 DNA复制。本产品可以有效地预防细胞培养过程中支原体的污染，同时还能预防常见的革兰氏阳性菌和阴性菌，日常细胞培养中替代双抗使用效果更好，作用浓度低，几乎没有细胞毒性。
支原体介绍视频
Wang S, Han Q, Qin W, et al. PhenoModel: A multimodal phenotypic drug design foundation model for discovering novel potential inhibitors of multiple cancer cells[J]. Acta Pharmaceutica Sinica B, 2025.(IF 14.60)
Zhang Y, Li Y, Zhang Z, et al. CD49a targeting enhances NK cell function and antitumor immunity[J]. Cancer Immunology Research, 2025.(IF 8.20)
Zhang Y, Li Y, Zhang Z, et al. CD49a targeting enhances NK cell function and antitumor immunity[J]. Cancer Immunology Research, 2025.(IF 8.10)
Gao J, Li C, Wang X, et al. Oridonin attenuates lung inflammation and fibrosis in silicosis via covalent targeting iNOS[J]. Biomedicine & Pharmacotherapy, 2022.(IF 7.41)
Ye H, Kang L, Yan X, et al. MiR-103a-3p promotes Zika virus replication by targeting OTU Deubiquitinase 4 to activate p38 mitogen-activated protein kinase signaling pathway[J]. Frontiers in Microbiology, 2022.(IF 6.06)
Lin S, Yan X, Zhu L, et al. Early detection of gastric cancer via multiplex blood assay targeting CfDNA methylation signatures[J]. Gastric Cancer, 2026.(IF 5.10)
Gong C, Wang D, Zhang Q. HuangLian-4 alleviates myocardial ischemia-reperfusion injury by activating the pro-survival STAT3 signaling pathway[J]. Frontiers in Pharmacology, 2025.(IF 4.80)
